Haemoglobin targets: we were wrong, time to move on

Lancet. 2007 Feb 3;369(9559):346-50. doi: 10.1016/S0140-6736(07)60165-2.
No abstract available

Publication types

  • Comment

MeSH terms

  • Anemia / complications
  • Anemia / drug therapy*
  • Cardiovascular Diseases / chemically induced*
  • Cardiovascular Diseases / mortality
  • Dose-Response Relationship, Drug
  • Erythropoietin / administration & dosage
  • Erythropoietin / adverse effects*
  • Erythropoietin / therapeutic use
  • Hemoglobins / drug effects*
  • Humans
  • Kidney Failure, Chronic / complications
  • Kidney Failure, Chronic / drug therapy*
  • Randomized Controlled Trials as Topic
  • Recombinant Proteins
  • Risk

Substances

  • Hemoglobins
  • Recombinant Proteins
  • Erythropoietin